Peer-influenced content. Sources you trust. No registration required. This is HCN.

Latest From Journal of Clinical Oncology


The Journal of Clinical Oncology (JCO), an American Society of Clinical Oncology (ASCO) journal, serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.

JCO‘s audience comprises medical professionals from all oncology disciplines and subspecialties including medical, surgical, pediatric, gynecologic, and urologic oncology, therapeutic radiology, and hematology. Readers are physicians, researchers, oncology nurses, and other health care practitioners with a predominant interest in oncology.

JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form